Rare Disease Report: Is Eteplirsen Effective in Non-ambulatory Duchenne Patients?
February 1, 2016
Christine McSherry, founder of the Jett Foundation talks about her son’s experience as a non-ambulatory Duchenne muscular dystrophy patient taking Sarepta’s eteplirsen.

Stay Connected
Sign up for updates straight to your inbox.